干细胞生命医学应用临床报告（英文）

萌了个乖乖

干细胞生命医学应用临床报告（英文）
1 Table of Contents
1 Table of Contents ........................................................................................................................................................ 2
1.1 List of Figures ................................................................................................................................................................... 3
2 Introduction ................................................................................................................................................................ 4
2.1 Report Scope .................................................................................................................................................................... 4
2.2 Methodology .................................................................................................................................................................... 4
2.3 Organizations Mentioned................................................................................................................................................. 4
3 Stem Cell Therapy Trial Landscape ............................................................................................................................... 5
3.1 Introduction ..................................................................................................................................................................... 5
3.2 Stem Cell Therapy Clinical Trials by Phase and Sponsor Type, 2007–2016 ...................................................................... 5
3.3 Single-Country and Multinational Stem Cell Therapy Trials, 2007–2016 ......................................................................... 8
3.4 Average Size of Stem Cell Therapy Clinical Trials, 2007–2016 ......................................................................................... 9
3.5 Stem Cell Therapy Clinical Trials by Therapy Area, 2007–2016 .....................................................................................11
3.6 Top Indications for Stem Cell Therapy Clinical Trials, 2007–2016..................................................................................12
3.7 Stem Cell Therapy Clinical Trials by Status, 2007–2016 .................................................................................................14
3.8 Top Sponsors for Stem Cell Therapy Clinical Trials, 2007–2016 ....................................................................................15
3.9 Top Interventions Investigated in Stem Cell Therapy Clinical Trials, 2007–2016 ...........................................................17
3.10 Stem Cell Therapy Clinical Trials by Country, 2007–2016 ..............................................................................................18
4 Summary .................................................................................................................................................................. 19
5 About the Authors .................................................................................................................................................... 20
5.1 Associate Analyst, Clinical Trials Database .....................................................................................................................20
5.2 Global Director of Databases and Analytics ...................................................................................................................20
6 About the Pharmaceutical Clinical Trials Team ........................................................................................................... 21
7 About GlobalData...................................................................................................................................................... 22
7.1 Contact Us ......................................................................................................................................................................22
7.2 Disclaimer .......................................................................................................................................................................23